Document is current
Any future updates will be listed below
-
Authors
Klepzig, Hanna https://orcid.org/0009-0007-8369-8115
Herling, Marco
Pflug, Natali
Braun, Till https://orcid.org/0000-0002-0854-7815
-
Funding
Funding for this research was provided by:
Dr. Mildred Scheel Stiftung für Krebsforschung (70113307)
Wilhelm Sander-Stiftung (No. 2023.084.1, No. 2023.084.1)
José Carreras Leukämie-Stiftung (DJCLS 01 R_2023)
Deutsche Forschungsgemeinschaft (PF1028/1-1)
- License Information
-
More Information
Article History
Received: 18 December 2024
Revised: 5 February 2025
Accepted: 24 February 2025
First Online: 7 March 2025
Competing interests
: MH gave advisory boards and received honoraria from Abbvie, Beigene, Jazz, Janssen, Stemline Menarini, and Takeda, and received research support from EDO-Mundipharma, Janpix, Novartis, and Roche.
